USA Change Macroaxis User Registration

Home Portfolios Solutions About Us

More ROI Blog

Marketplace Community ScreenersEfficient FrontierCorrelationsRisk/Return

US Market Open: Feb 9, 15:43 PM 2012

NYSE 8085.95 2.97 Index Moved Up

NASDAQ 2927.99 12.13 Index Moved Up

and more..

sponsered by

Processing
Collecting necessary data for ALKS and HSP...

Asset Comparison and Correlation

View All Portfolios

More Actions
- Select Assests
- Optimize Portfolio
- Suggest Portfolio
- Backtest Watchlist
- Analyze Correlations
- View Transactions
- Check Volatilities
- Import Equities
- Search Equities
- Filter Tops

Alkermes Inc. and

Hospira Inc

Volatility

Matrix

Run Correlation

Diversification

Very weak diversification

Overlapping area represents amount of risk that can be diversified away by holding Alkermes Inc. and Hospira Inc in the same portfolio (assuming nothing else is changed)

Optimize

Correlation Coefficient

0.45

Parameters

Time Period	1 Month [change]
Direction	Positive
Strength	Weak
Accuracy	95.83%
Values	Daily Returns

Suggest

Alkermes Inc.

Profile

18.54

Intraday

One Month

^(0.34)

1.80%

ALKS

NASDAQ

Alkermes Inc.

Day Low	18.46	Open	19.04
P/B Ratio	2.71	Market Cap	2.405B
Volume	434708	Sector	Healthcare
Last Close	18.88	Founded	Yes
Short Ratio	7.60	Last Traded	2/9/2012
Year High	20.00	Percent Change	1.80%
EBITDA	12.2M	Year Low	11.86
Absolute Change	0.34	Time	Not Applicable
Book Value	6.974	EPS	-0.60
PEG Ratio	0.13	Employees	600
Day High	19.05	Industry	Drug Delivery
Target Price	21.90	Current EPS	-0.60
This Year EPS	-0.62	Next Year EPS	-0.28

Hospira Inc

Profile

34.15

Intraday

One Month

^(0.60)

1.73%

HSP

NYSE

Hospira Inc

P/E	22.12	Day Low	33.71
Open	34.70	P/B Ratio	1.80
Market Cap	5.625B	Volume	1891261
Sector	Healthcare	Last Close	34.75
Short Ratio	2.80	Last Traded	2/9/2012
Year High	59.20	Percent Change	1.73%
EBITDA	791.6M	Year Low	26.92
Absolute Change	0.60	Time	Not Applicable
Book Value	19.359	EPS	1.571
PEG Ratio	2.57	Employees	14,000
Day High	34.76	Industry	Drug Delivery
Target Price	32.92	Current EPS	1.571
This Year EPS	2.99	Next Year EPS	2.43
Current PE	22.12	This Year PE	11.62
Next Year PE	14.30	Dividend	Not Applicable